Dan Shelly, PhD, on Developing an Allogeneic, Adaptable CAR Platform
We can profile the patient, find out what they need, we pull the appropriate targeting...
We can profile the patient, find out what they need, we pull the appropriate targeting...
This investor centre was built by Reach Markets
©2022 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.